Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy
基于可溶性和细胞相关(免疫)标志物多重分析的乳腺癌评分有助于预测帕博利珠单抗治疗效果
期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03729-7
Schweihofer, Verena; Bruss, Christina; Seitz, Stephan; Glehr, Gunther; Hetterich, Madeleine; Weber, Florian; Hatzipanagiotou, Maria; Álvarez, Miriam Fernández-Pacheco; Ortmann, Olaf; Brockhoff, Gero; Bauer, Richard J; Wege, Anja Kathrin